- Home
- / Dashenlin Pharmaceutical Group
Dashenlin Pharmaceutical Group
Stock Price
¥14.7
2024-10-29
Market Capitalization
¥16.5 B
2024-10-29
Revenue
¥26.7 B
FY, 2025
Dashenlin Pharmaceutical Group Summary
Company Summary
- Overview
- Dashenlin Pharmaceutical Group (大参林医药集团股份有限公司) is a company that specializes in pharmaceutical manufacturing, retail, and wholesale businesses. It offers cold medicines, nutritional supplements, vitamins, minerals, tobacco, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1999
- HQ
- Guangzhou, CN | view all locations
- Website
- https://www.dslyy.com
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Guangzhou, Guang Dong Sheng HQ
China
No. 410, No. 410-1, Longxi Avenue
Dashenlin Pharmaceutical Group Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥6.9B
- Gross profit (Q1, 2026)
- ¥2.5B
- Net income (Q1, 2026)
- ¥543.6M
- Cash (Q1, 2026)
- ¥6.9B
- EBIT (Q1, 2026)
- ¥732.4M
- Enterprise value
- $21.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026